The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Lansoprazole Market Research Report 2024
Synopsis
Lansoprazole drug in this report.
The global Lansoprazole market was valued at US$ 362 million in 2023 and is anticipated to reach US$ 541.2 million by 2030, witnessing a CAGR of 6.4% during the forecast period 2024-2030.
North American market for Lansoprazole is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Lansoprazole is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global manufacturers of Lansoprazole include Takeda Pharmaceutical, Teva Pharms, Sandoz, GSK, Dr. Reddy's, Pfizer, Taj Pharma, Mylan and Cisen Pharmaceutical, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Lansoprazole, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Lansoprazole.
Report Scope
The Lansoprazole market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Lansoprazole market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Lansoprazole manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Takeda Pharmaceutical
Teva Pharms
Sandoz
GSK
Dr. Reddy's
Pfizer
Taj Pharma
Mylan
Cisen Pharmaceutical
Lepu Pharmaceuticals
Nang Kuang Pharmaceutical
Luoxin Biotechnology
Beijing Honglin Pharma.
Suzhou YUSHI Pharmaceutical Co.
Changzhou Siyao Pharmaceuticals
Youcare Pharmaceutical Group
HOPE PHARMA
Sun Pharmaceutical Industries
Krka
Segment by Type
Capsules
Tablets
Injection
Segment by Application
Male
Female
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Lansoprazole manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Lansoprazole in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Lansoprazole drug in this report.
The global Lansoprazole market was valued at US$ 362 million in 2023 and is anticipated to reach US$ 541.2 million by 2030, witnessing a CAGR of 6.4% during the forecast period 2024-2030.
North American market for Lansoprazole is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Lansoprazole is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global manufacturers of Lansoprazole include Takeda Pharmaceutical, Teva Pharms, Sandoz, GSK, Dr. Reddy's, Pfizer, Taj Pharma, Mylan and Cisen Pharmaceutical, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Lansoprazole, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Lansoprazole.
Report Scope
The Lansoprazole market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Lansoprazole market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Lansoprazole manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Takeda Pharmaceutical
Teva Pharms
Sandoz
GSK
Dr. Reddy's
Pfizer
Taj Pharma
Mylan
Cisen Pharmaceutical
Lepu Pharmaceuticals
Nang Kuang Pharmaceutical
Luoxin Biotechnology
Beijing Honglin Pharma.
Suzhou YUSHI Pharmaceutical Co.
Changzhou Siyao Pharmaceuticals
Youcare Pharmaceutical Group
HOPE PHARMA
Sun Pharmaceutical Industries
Krka
Segment by Type
Capsules
Tablets
Injection
Segment by Application
Male
Female
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Lansoprazole manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Lansoprazole in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Index1 Lansoprazole Market Overview
1.1 Product Overview and Scope of Lansoprazole
1.2 Lansoprazole Segment by Type
1.2.1 Global Lansoprazole Market Value Comparison by Type (2024-2030)
1.2.2 Capsules
1.2.3 Tablets
1.2.4 Injection
1.3 Lansoprazole Segment by Application
1.3.1 Global Lansoprazole Market Value by Application: (2024-2030)
1.3.2 Male
1.3.3 Female
1.4 Global Lansoprazole Market Size Estimates and Forecasts
1.4.1 Global Lansoprazole Revenue 2019-2030
1.4.2 Global Lansoprazole Sales 2019-2030
1.4.3 Global Lansoprazole Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Lansoprazole Market Competition by Manufacturers
2.1 Global Lansoprazole Sales Market Share by Manufacturers (2019-2024)
2.2 Global Lansoprazole Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Lansoprazole Average Price by Manufacturers (2019-2024)
2.4 Global Lansoprazole Industry Ranking 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Lansoprazole, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Lansoprazole, Product Type & Application
2.7 Lansoprazole Market Competitive Situation and Trends
2.7.1 Lansoprazole Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Lansoprazole Players Market Share by Revenue
2.7.3 Global Lansoprazole Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Lansoprazole Retrospective Market Scenario by Region
3.1 Global Lansoprazole Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Lansoprazole Global Lansoprazole Sales by Region: 2019-2030
3.2.1 Global Lansoprazole Sales by Region: 2019-2024
3.2.2 Global Lansoprazole Sales by Region: 2025-2030
3.3 Global Lansoprazole Global Lansoprazole Revenue by Region: 2019-2030
3.3.1 Global Lansoprazole Revenue by Region: 2019-2024
3.3.2 Global Lansoprazole Revenue by Region: 2025-2030
3.4 North America Lansoprazole Market Facts & Figures by Country
3.4.1 North America Lansoprazole Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Lansoprazole Sales by Country (2019-2030)
3.4.3 North America Lansoprazole Revenue by Country (2019-2030)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Lansoprazole Market Facts & Figures by Country
3.5.1 Europe Lansoprazole Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Lansoprazole Sales by Country (2019-2030)
3.5.3 Europe Lansoprazole Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Lansoprazole Market Facts & Figures by Country
3.6.1 Asia Pacific Lansoprazole Market Size by Country: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Lansoprazole Sales by Country (2019-2030)
3.6.3 Asia Pacific Lansoprazole Revenue by Country (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Lansoprazole Market Facts & Figures by Country
3.7.1 Latin America Lansoprazole Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Lansoprazole Sales by Country (2019-2030)
3.7.3 Latin America Lansoprazole Revenue by Country (2019-2030)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Lansoprazole Market Facts & Figures by Country
3.8.1 Middle East and Africa Lansoprazole Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Lansoprazole Sales by Country (2019-2030)
3.8.3 Middle East and Africa Lansoprazole Revenue by Country (2019-2030)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Lansoprazole Sales by Type (2019-2030)
4.1.1 Global Lansoprazole Sales by Type (2019-2024)
4.1.2 Global Lansoprazole Sales by Type (2025-2030)
4.1.3 Global Lansoprazole Sales Market Share by Type (2019-2030)
4.2 Global Lansoprazole Revenue by Type (2019-2030)
4.2.1 Global Lansoprazole Revenue by Type (2019-2024)
4.2.2 Global Lansoprazole Revenue by Type (2025-2030)
4.2.3 Global Lansoprazole Revenue Market Share by Type (2019-2030)
4.3 Global Lansoprazole Price by Type (2019-2030)
5 Segment by Application
5.1 Global Lansoprazole Sales by Application (2019-2030)
5.1.1 Global Lansoprazole Sales by Application (2019-2024)
5.1.2 Global Lansoprazole Sales by Application (2025-2030)
5.1.3 Global Lansoprazole Sales Market Share by Application (2019-2030)
5.2 Global Lansoprazole Revenue by Application (2019-2030)
5.2.1 Global Lansoprazole Revenue by Application (2019-2024)
5.2.2 Global Lansoprazole Revenue by Application (2025-2030)
5.2.3 Global Lansoprazole Revenue Market Share by Application (2019-2030)
5.3 Global Lansoprazole Price by Application (2019-2030)
6 Key Companies Profiled
6.1 Takeda Pharmaceutical
6.1.1 Takeda Pharmaceutical Corporation Information
6.1.2 Takeda Pharmaceutical Description and Business Overview
6.1.3 Takeda Pharmaceutical Lansoprazole Sales, Revenue and Gross Margin (2019-2024)
6.1.4 Takeda Pharmaceutical Lansoprazole Product Portfolio
6.1.5 Takeda Pharmaceutical Recent Developments/Updates
6.2 Teva Pharms
6.2.1 Teva Pharms Corporation Information
6.2.2 Teva Pharms Description and Business Overview
6.2.3 Teva Pharms Lansoprazole Sales, Revenue and Gross Margin (2019-2024)
6.2.4 Teva Pharms Lansoprazole Product Portfolio
6.2.5 Teva Pharms Recent Developments/Updates
6.3 Sandoz
6.3.1 Sandoz Corporation Information
6.3.2 Sandoz Description and Business Overview
6.3.3 Sandoz Lansoprazole Sales, Revenue and Gross Margin (2019-2024)
6.3.4 Sandoz Lansoprazole Product Portfolio
6.3.5 Sandoz Recent Developments/Updates
6.4 GSK
6.4.1 GSK Corporation Information
6.4.2 GSK Description and Business Overview
6.4.3 GSK Lansoprazole Sales, Revenue and Gross Margin (2019-2024)
6.4.4 GSK Lansoprazole Product Portfolio
6.4.5 GSK Recent Developments/Updates
6.5 Dr. Reddy's
6.5.1 Dr. Reddy's Corporation Information
6.5.2 Dr. Reddy's Description and Business Overview
6.5.3 Dr. Reddy's Lansoprazole Sales, Revenue and Gross Margin (2019-2024)
6.5.4 Dr. Reddy's Lansoprazole Product Portfolio
6.5.5 Dr. Reddy's Recent Developments/Updates
6.6 Pfizer
6.6.1 Pfizer Corporation Information
6.6.2 Pfizer Description and Business Overview
6.6.3 Pfizer Lansoprazole Sales, Revenue and Gross Margin (2019-2024)
6.6.4 Pfizer Lansoprazole Product Portfolio
6.6.5 Pfizer Recent Developments/Updates
6.7 Taj Pharma
6.6.1 Taj Pharma Corporation Information
6.6.2 Taj Pharma Description and Business Overview
6.6.3 Taj Pharma Lansoprazole Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Taj Pharma Lansoprazole Product Portfolio
6.7.5 Taj Pharma Recent Developments/Updates
6.8 Mylan
6.8.1 Mylan Corporation Information
6.8.2 Mylan Description and Business Overview
6.8.3 Mylan Lansoprazole Sales, Revenue and Gross Margin (2019-2024)
6.8.4 Mylan Lansoprazole Product Portfolio
6.8.5 Mylan Recent Developments/Updates
6.9 Cisen Pharmaceutical
6.9.1 Cisen Pharmaceutical Corporation Information
6.9.2 Cisen Pharmaceutical Description and Business Overview
6.9.3 Cisen Pharmaceutical Lansoprazole Sales, Revenue and Gross Margin (2019-2024)
6.9.4 Cisen Pharmaceutical Lansoprazole Product Portfolio
6.9.5 Cisen Pharmaceutical Recent Developments/Updates
6.10 Lepu Pharmaceuticals
6.10.1 Lepu Pharmaceuticals Corporation Information
6.10.2 Lepu Pharmaceuticals Description and Business Overview
6.10.3 Lepu Pharmaceuticals Lansoprazole Sales, Revenue and Gross Margin (2019-2024)
6.10.4 Lepu Pharmaceuticals Lansoprazole Product Portfolio
6.10.5 Lepu Pharmaceuticals Recent Developments/Updates
6.11 Nang Kuang Pharmaceutical
6.11.1 Nang Kuang Pharmaceutical Corporation Information
6.11.2 Nang Kuang Pharmaceutical Lansoprazole Description and Business Overview
6.11.3 Nang Kuang Pharmaceutical Lansoprazole Sales, Revenue and Gross Margin (2019-2024)
6.11.4 Nang Kuang Pharmaceutical Lansoprazole Product Portfolio
6.11.5 Nang Kuang Pharmaceutical Recent Developments/Updates
6.12 Luoxin Biotechnology
6.12.1 Luoxin Biotechnology Corporation Information
6.12.2 Luoxin Biotechnology Lansoprazole Description and Business Overview
6.12.3 Luoxin Biotechnology Lansoprazole Sales, Revenue and Gross Margin (2019-2024)
6.12.4 Luoxin Biotechnology Lansoprazole Product Portfolio
6.12.5 Luoxin Biotechnology Recent Developments/Updates
6.13 Beijing Honglin Pharma.
6.13.1 Beijing Honglin Pharma. Corporation Information
6.13.2 Beijing Honglin Pharma. Lansoprazole Description and Business Overview
6.13.3 Beijing Honglin Pharma. Lansoprazole Sales, Revenue and Gross Margin (2019-2024)
6.13.4 Beijing Honglin Pharma. Lansoprazole Product Portfolio
6.13.5 Beijing Honglin Pharma. Recent Developments/Updates
6.14 Suzhou YUSHI Pharmaceutical Co.
6.14.1 Suzhou YUSHI Pharmaceutical Co. Corporation Information
6.14.2 Suzhou YUSHI Pharmaceutical Co. Lansoprazole Description and Business Overview
6.14.3 Suzhou YUSHI Pharmaceutical Co. Lansoprazole Sales, Revenue and Gross Margin (2019-2024)
6.14.4 Suzhou YUSHI Pharmaceutical Co. Lansoprazole Product Portfolio
6.14.5 Suzhou YUSHI Pharmaceutical Co. Recent Developments/Updates
6.15 Changzhou Siyao Pharmaceuticals
6.15.1 Changzhou Siyao Pharmaceuticals Corporation Information
6.15.2 Changzhou Siyao Pharmaceuticals Lansoprazole Description and Business Overview
6.15.3 Changzhou Siyao Pharmaceuticals Lansoprazole Sales, Revenue and Gross Margin (2019-2024)
6.15.4 Changzhou Siyao Pharmaceuticals Lansoprazole Product Portfolio
6.15.5 Changzhou Siyao Pharmaceuticals Recent Developments/Updates
6.16 Youcare Pharmaceutical Group
6.16.1 Youcare Pharmaceutical Group Corporation Information
6.16.2 Youcare Pharmaceutical Group Lansoprazole Description and Business Overview
6.16.3 Youcare Pharmaceutical Group Lansoprazole Sales, Revenue and Gross Margin (2019-2024)
6.16.4 Youcare Pharmaceutical Group Lansoprazole Product Portfolio
6.16.5 Youcare Pharmaceutical Group Recent Developments/Updates
6.17 HOPE PHARMA
6.17.1 HOPE PHARMA Corporation Information
6.17.2 HOPE PHARMA Lansoprazole Description and Business Overview
6.17.3 HOPE PHARMA Lansoprazole Sales, Revenue and Gross Margin (2019-2024)
6.17.4 HOPE PHARMA Lansoprazole Product Portfolio
6.17.5 HOPE PHARMA Recent Developments/Updates
6.18 Sun Pharmaceutical Industries
6.18.1 Sun Pharmaceutical Industries Corporation Information
6.18.2 Sun Pharmaceutical Industries Lansoprazole Description and Business Overview
6.18.3 Sun Pharmaceutical Industries Lansoprazole Sales, Revenue and Gross Margin (2019-2024)
6.18.4 Sun Pharmaceutical Industries Lansoprazole Product Portfolio
6.18.5 Sun Pharmaceutical Industries Recent Developments/Updates
6.19 Krka
6.19.1 Krka Corporation Information
6.19.2 Krka Lansoprazole Description and Business Overview
6.19.3 Krka Lansoprazole Sales, Revenue and Gross Margin (2019-2024)
6.19.4 Krka Lansoprazole Product Portfolio
6.19.5 Krka Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Lansoprazole Industry Chain Analysis
7.2 Lansoprazole Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Lansoprazole Production Mode & Process
7.4 Lansoprazole Sales and Marketing
7.4.1 Lansoprazole Sales Channels
7.4.2 Lansoprazole Distributors
7.5 Lansoprazole Customers
8 Lansoprazole Market Dynamics
8.1 Lansoprazole Industry Trends
8.2 Lansoprazole Market Drivers
8.3 Lansoprazole Market Challenges
8.4 Lansoprazole Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
